Sign In  |  Register  |  About San Rafael  |  Contact Us

San Rafael, CA
September 01, 2020 1:37pm
7-Day Forecast | Traffic

  • Search Hotels in San Rafael

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

118.60 +5.23 (+4.61%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
40 41 Next >
Abbott Laboratories: Debt Overview
Shares of Abbott Laboratories (NYSE:ABT) moved higher by 8.53% in the past three months. Before we understand the importance of debt, let us look at how much debt Abbott... 
Via Benzinga
This Cardiac Device Could Possibly Be the Game Changer That Saves Millions of Lives
Photo by Jesse Orrico on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial... 
Via Benzinga
Abbott Laboratories: The Winning Streak Continues
Abbott Laboratories (NYSE: ABT) traded at a new 12-month high today of $139.11. Approximately 4 million shares have changed hands today, as compared to an average 30-day volume of... 
Via Benzinga
Abbott Laboratories (ABT): The Winning Streak Continues
Via Investor Brand Network
$1000 Invested In This Stock Over The Last 5 Years, Would Be Worth This Much
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 5 years by 13.08% on an annualized basis. Buying $1,000.00 In ABT: 5 years ago, an investor could have... 
Via Benzinga
Johnson & Johnson: What Should Investors Do Following The Consumer Health Spinoff?
A sizeable change in direction for one of the country’s oldest companies was probably a shock to many shareholders. 
Via Talk Markets
Expert Ratings For Abbott Laboratories
Within the last quarter, Abbott Laboratories (NYSE:ABT) has observed the follo... 
Via Benzinga
Abbott and ADA Launch First Joint Community Initiative
SOURCE: Abbott 
Via 3BL Media
3 Coronavirus Stocks To Buy In December
Moderna is the leading company in the development of messenger RNA-based medicines and vaccines to treat infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune... 
Via Talk Markets
Exposures COVID-19
3 Healthcare Stocks for Long-Term Dividend Growth
Dividend investors face a variety of choices. We like healthcare stocks for many reasons, such as long-term earnings growth. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021
Upgrades According to JP Morgan, the prior rating for Arconic Corp (NYSE: 
Via Benzinga
Here's How Much $100 Invested In Abbott Laboratories 5 Years Ago Would Be Worth Today
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 5 years by 12.02% on an annualized basis. Buying $100.00 In ABT: 5 years ago, an investor could have... 
Via Benzinga
This Biotech CEO Is Trying To Cure His Son's Rare Disease
Few questions stump Tim Walbert. But the Horizon Therapeutics CEO is still working to answer one of them from his son. 
Via Investor's Business Daily
Watch for Continued Gains in Shares of Abbott Laboratories
Shares of Abbott Laboratories (NYSE: ABT) traded today at $132.41, eclipsing its 12-month high. Approximately 1.4 million shares have changed hands today, as compared to an... 
Via Benzinga
How Did Healthcare Stocks Perform Over This Volatile Month?
It’s been a rough month for small-cap biotech stocks amidst a general correction in the market which brought general indices down about 10%. 
Via Talk Markets
Watch for Continued Gains in Shares of Abbott Laboratories
Shares of Abbott Laboratories (NYSE: ABT) traded today at $132.41, eclipsing its 12-month high. Approximately 1.4 million shares have changed hands today, as compared to an... 
Via Benzinga
7 Stocks to Buy to Give Your Portfolio a Booster Shot
With the new strain already reported in the U.S., it’s time to consider some adjustments to your portfolio. 
Via InvestorPlace
Exposures COVID-19
Abbott Labs Stock Climbs Into Top-Performers Group Amid Continued double- and triple-digit Profit, Sales Growth
A Relative Strength Rating upgrade for Abbott Laboratories shows improving technical performance. 
Via Investor's Business Daily
Flu, Meet COVID-19: What to Know About This Season
SOURCE: Abbott 
Via 3BL Media
Topics Economy
Exposures COVID-19 Economy
Even Good Penny Stocks Like Senseonics Aren’t Always Profitable
Its latest implanted sensor lasts six months, but SENS stock faces competition from Dexcom, Abbott Labs and potentially one big name in tech. 
Via InvestorPlace
Biden's New COVID-19 Plan Includes Reimbursement For Over The Counter, At-Home COVID Tests
President Biden announced that private health insurance plans would soon reimburse people who buy over-the-counter (OTC), at-home rapid tests for COVID-19. What Happened... 
Via Benzinga
Exposures COVID-19
A Lasting Impact Through Better Medicine Adherence
SOURCE: Abbott 
Via 3BL Media
Topics Death
Exposures Death
Notable Abbott Laboratories Insider Trades $5.5M In Company Stock
Gregory A Ahlberg, Insider at Abbott Laboratories (NYSE:ABT), made a large buy and sell of company shares on November 15, according to a new SEC filing. What Happened: A Form 4... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
Danaher Stock Shows Renewed Strength, Earning Key Rating Hike Amid Rising Profits, Sales
A Relative Strength Rating upgrade for Danaher shows improving technical performance. Will it continue? 
Via Investor's Business Daily
Abbott Named to the Corporate Citizenship Hall of Fame
SOURCE: Abbott 
Via 3BL Media
Better Buy: DexCom or Abbott Labs?
Abbott's the heavyweight, and DexCom is the formidable challenger. 
Via The Motley Fool
The Daily Biotech Pulse: Kezar Jumps On Data, Biogen R&D Chief To Retire, Molecular Partners Wilts On COVID Trial Disappointment
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Kezar Life Sciences Reports Positive Interim Phase 2 Data For Lupus Nephritis... 
Via Benzinga
Abbott Achieves Highest Score in Its Industry for the Ninth Consecutive Year on the Dow Jones Sustainability Index (DJSI)
SOURCE: Abbott 
Via 3BL Media
Topics Stocks
Exposures US Equities
Johnson & Johnson Pops As It Announces The Biggest Split In Health Care
Johnson & Johnson will split its consumer health unit into a publicly traded company. 
Via Investor's Business Daily
A (Virtual) Field Trip Into the Heart
SOURCE: Abbott 
Via 3BL Media
< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
40 41 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanRafael.com & California Media Partners, LLC. All rights reserved.